2012
DOI: 10.1074/jbc.m111.311159
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Determinants for Antibody Binding on Group 1 House Dust Mite Allergens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

9
97
1
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 79 publications
(116 citation statements)
references
References 57 publications
9
97
1
1
Order By: Relevance
“…In 4C1 interactions Tyr and Arg were particularly prominent, with potential contributions from hydrogen bonding, π bonding, and hydrophobic interactions. Interestingly, hydrogen-bonding networks in the binding interfaces of the 16 allergens were most frequently formed by Arg-Asp, Arg-Tyr, Asp-Arg, Asp-Tyr, Glu-Arg, Glu-Ser, and Gln-Ser pairs, distinct from a number of lysozyme-antibody complexes where Arg-Glu, Arg-Tyr, Asn-Gln, Asp-Ser, and Lys-Asp predominated [17].…”
Section: Current Perspectivesmentioning
confidence: 99%
See 3 more Smart Citations
“…In 4C1 interactions Tyr and Arg were particularly prominent, with potential contributions from hydrogen bonding, π bonding, and hydrophobic interactions. Interestingly, hydrogen-bonding networks in the binding interfaces of the 16 allergens were most frequently formed by Arg-Asp, Arg-Tyr, Asp-Arg, Asp-Tyr, Glu-Arg, Glu-Ser, and Gln-Ser pairs, distinct from a number of lysozyme-antibody complexes where Arg-Glu, Arg-Tyr, Asn-Gln, Asp-Ser, and Lys-Asp predominated [17].…”
Section: Current Perspectivesmentioning
confidence: 99%
“…Potent allergens in house dust mites include the cysteine proteases Der p 1 and Der f 1, which induce a strong response of IgE antibodies [17]. These antigens share 81 % sequence identity and elicit highly crossreactive responses.…”
Section: Current Perspectivesmentioning
confidence: 99%
See 2 more Smart Citations
“…Based upon the success of recombinant allergens, rational design of allergenic epitopes was the next logical step, since, as far back as 1970, allergens were being chemically modified to reduce IgE binding capacity while retaining the ability to prompt the production of antigen-specific IgGs (122,123). More recently, the use of recombinant technology yielded new tools with which to mutate specific residues that alter the activity of the allergen.…”
Section: Active Allergen Immunotherapy Induces Neutralizing Antibodymentioning
confidence: 99%